Clinical trial
Prognostic Value of Plasma Biomarkers Among Patients With Hypertension
NCT04107584 is registered in ClinicalTrials.gov with Beijing Institute of Heart, Lung and Blood Vessel Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of Plasma Biomarkers Among Patients With Hypertension
- Lead sponsor
- Beijing Institute of Heart, Lung and Blood Vessel Diseases
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2017
- Completion date
- August 31, 2022
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.